Takayanagui OM - Search Results

1

Enantioselective analysis of albendazole sulfoxide in cerebrospinal fluid by capillary electrophoresis.

Paias FO, Lanchote VL, Takayanagui OM, Bonato PS. Paias FO, et al. Among authors: takayanagui om. Electrophoresis. 2001 Sep;22(15):3263-9. doi: 10.1002/1522-2683(200109)22:15<3263::AID-ELPS3263>3.0.CO;2-4. Electrophoresis. 2001. PMID: 11589289

2

Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis.

Lanchote VL, Garcia FS, Dreossi SA, Takayanagui OM. Lanchote VL, et al. Among authors: takayanagui om. Ther Drug Monit. 2002 Jun;24(3):338-45. doi: 10.1097/00007691-200206000-00003. Ther Drug Monit. 2002. PMID: 12021623 Clinical Trial.

3

Simultaneous liquid chromatography-tandem mass spectrometric determination of albendazole sulfoxide and albendazole sulfone in plasma.

Bonato PS, Lanchote VL, Takayanagui OM. Bonato PS, et al. Among authors: takayanagui om. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jan 5;783(1):237-45. doi: 10.1016/s1570-0232(02)00665-7. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 12450544

4

Enantioselective analysis of praziquantel and trans-4-hydroxypraziquantel in human plasma by chiral LC-MS/MS: Application to pharmacokinetics.

Lima RM, Ferreira MA, Ponte TM, Marques MP, Takayanagui OM, Garcia HH, Coelho EB, Bonato PS, Lanchote VL. Lima RM, et al. Among authors: takayanagui om. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Oct 1;877(27):3083-8. doi: 10.1016/j.jchromb.2009.07.036. Epub 2009 Aug 3. J Chromatogr B Analyt Technol Biomed Life Sci. 2009. PMID: 19665946

5

Therapy for neurocysticercosis: pharmacokinetic interaction of albendazole sulfoxide with dexamethasone.

Takayanagui OM, Lanchote VL, Marques MP, Bonato PS. Takayanagui OM, et al. Ther Drug Monit. 1997 Feb;19(1):51-5. doi: 10.1097/00007691-199702000-00009. Ther Drug Monit. 1997. PMID: 9029747 Clinical Trial.

6

Enantioselective analysis of albendazole sulfoxide in plasma using the chiral stationary phase.

Paias FO, Lanchote VL, Takayanagui OM, Bonato PS. Paias FO, et al. Among authors: takayanagui om. Chirality. 1997;9(8):722-6. doi: 10.1002/(SICI)1520-636X(1997)9:8<722::AID-CHIR2>3.0.CO;2-7. Chirality. 1997. PMID: 9435097 Clinical Trial.

7

Simultaneous determination of albendazole sulfoxide enantiomers and albendazole sulfone in plasma.

Lanchote VL, Marques MP, Takayanagui OM, de Carvalho R, Paias FO, Bonato PS. Lanchote VL, et al. Among authors: takayanagui om. J Chromatogr B Biomed Sci Appl. 1998 May 29;709(2):273-9. doi: 10.1016/s0378-4347(98)00082-6. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9657224

8

Enantioselective kinetic disposition of albendazole sulfoxide in patients with neurocysticercosis.

Marques MP, Takayanagui OM, Bonato PS, Santos SR, Lanchote VL. Marques MP, et al. Among authors: takayanagui om. Chirality. 1999;11(3):218-23. doi: 10.1002/(SICI)1520-636X(1999)11:3<218::AID-CHIR8>3.0.CO;2-G. Chirality. 1999. PMID: 10079501 Clinical Trial.

9

Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis.

Takayanagui OM, Bonato PS, Dreossi SA, Lanchote VL. Takayanagui OM, et al. Br J Clin Pharmacol. 2002 Aug;54(2):125-30. doi: 10.1046/j.1365-2125.2002.01634.x. Br J Clin Pharmacol. 2002. PMID: 12207631 Free PMC article.

10

Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis.

Lanchote VL, Takayanagui OM, Mateus FH. Lanchote VL, et al. Among authors: takayanagui om. Chirality. 2004 Oct;16(8):520-5. doi: 10.1002/chir.20071. Chirality. 2004. PMID: 15290687

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters